Skip to content

Peri-procedural Smoking Cessation Program in Patients With Chronic Pain

Implementation of a Peri-procedural Smoking Cessation Program in Patients With Chronic Pain Undergoing Interventional Pain Management Procedures

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04605744
Enrollment
11
Registered
2020-10-28
Start date
2020-02-18
Completion date
2021-12-06
Last updated
2022-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain, Smoking

Brief summary

This single arm study will assess whether smoking cessation counseling offered to chronic pain patients is effective in reducing pain and cigarette use.

Interventions

BEHAVIORALSmoking cessation counseling

Patients will be given a briefing on the benefits of smoking cessation in the peri-procedural period around their interventional pain procedure. They will also be provided an informational sheet from the American Society of Anesthesiologists promoting cessation. The sheet will contain the 1-800-QUITNOW national hotline phone number. Additional an enrollment folder will provided that contains referral information to Cooper's Tobacco Cessation program. This service, free of charge to Cooper Health patients consists of 5 tobacco cessation counselors who use personalized cessation plans, individual and group counseling cessations, Chantix, and education to promote smoking cessation.

Sponsors

The Cooper Health System
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Chronic Pain of 3 months or greater * Scheduled for interventional pain procedure

Exclusion criteria

* Cancer related pain * Current participation in smoking abstinence program * History of schizophrenia or other pyschotic disorder * History of dementing illness * Pregnant patients * Diagnosis of depression or anxiety

Design outcomes

Primary

MeasureTime frameDescription
Pain6 monthsVisual analogue pain score

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026